This study discusses the role of core and symbolic capabilities during due-diligence processes when investing in companies in turbulent fields such as the biotechnology industry. The results indicate that investors' evaluations are hierarchical and are based on two premises. First, investors look for core capabilities - the characteristics that signal the potential for future success. They then search for symbolic elements, such as reputation, to confirm their decisions. The study expands earlier models of investors' evaluation processes. It also offers new insights for entrepreneurs of biotechnology firms.
|International Journal of Innovation and Technology Management
|מזהי עצם דיגיטלי (DOIs)
|פורסם - 22 דצמ׳ 2014
|פורסם באופן חיצוני
ASJC Scopus subject areas